Skip to main content
Clinical Trials/ITMCTR2100004975
ITMCTR2100004975
Recruiting
Phase 1

To Explore the Clinical Efficacy and Mechanism of optimized 'xiao-feng-san'

Overview

Phase
Phase 1
Intervention
Not specified
Conditions
chronic urticaria
Sponsor
Guang'anmen Hospital, China Academy of Chinese Medical Sciences
Status
Recruiting
Last Updated
3 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
3 years ago
Study Type
Interventional study
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • 1\. Patients aged 20 to 48 years;
  • 2\. patients conforming to the diagnostic criteria of refractory chronic urticaria;
  • 3\. patients conforming to the diagnostic criteria of TCM wind\-heat syndrome;
  • 4\. patients having used at least 2 times the conventional dose of antihistamines or at least 2 combined antihistamines with conventional dose for more than 2 weeks;
  • 5\. The duration of patients'hives is more than 2 hours;
  • 6\. patients able to give stool samples;
  • 7\. patients able to sign the informed consent form.

Exclusion Criteria

  • 1\. Patients dignosed drug\-induced urticaria, induced urticaria (cold urticaria, febrile urticaria, cholinergic urticaria), urticaria vasculitis and other skin diseases with urticaria\-like manifestations;
  • 2\. patients who have been treated well with antihistamines or have been treated with hormones, immunosuppressants, or biological agents, or have received relevant Chinese medicine treatment 1 week before enrollment,or Patients who have received antibiotics and non\-steroidal anti\-inflammatory drugs 2 weeks before enrollment;
  • 3\. patients who are pregnant, or preparing for pregnant, or breastfeeding women;
  • 4\. patients suffering serious organic diseases of important organs such as heart, brain, liver and kidney,and those with severe primary diseases of the hematopoietic system, and those with mental illness;
  • 5\. patients allergic to the components of Chinese medicine in the research prescription.

Outcomes

Primary Outcomes

Not specified

Similar Trials